Lv11
38 积分 2025-04-26 加入
Aberrant activation of TRIP13-EZH2 signaling axis promotes stemness and therapy resistance in multiple myeloma
29分钟前
待确认
METTL16 enhances proteasome inhibitor resistance in multiple myeloma by inhibiting eIF2α-PERK interaction and promoting PSMB5 translation
9天前
已完结
Decoding immunotherapy resistance in multiple myeloma: genetic insights and approaches to counter resistance
16天前
已完结
A region of deletion on chromosome 22q13 is common to human breast and colorectal cancers
1个月前
已关闭
Copy-number variation
1个月前
已完结
Multiple Myeloma
1个月前
已完结
Pathogenesis and therapeutic targeting of aberrant MYC expression in haematological cancers
4个月前
已完结
Large-scale dependency and drug screens to characterize the therapeutic vulnerabilities of multiple myeloma with 1q
5个月前
已完结
Targeting MYC in multiple myeloma
5个月前
已完结
Copy Number Aberration Analysis to Predict Response to Neoadjuvant Anti-HER2 Therapy: Results from the NeoALTTO Phase III Clinical Trial
5个月前
已完结
皖公网安备34019202002308
